干细胞检测市场规模、份额、成长分析、按产品类型、按检测类型、按应用、按最终用户、按地区 - 行业预测，2024-2031

2022年全球干细胞检测市场规模为19亿美元，从2023年的22.4亿美元成长到2031年的82.4亿美元，复合年增长率预计将成长17.7%。

由于难以获得的细胞类型的稳定可用性和生理相关模型的开发，干细胞检测市场正在经历显着增长。医疗基础设施和技术创新的最新进展正在改变治疗通讯协定并促进新治疗方法和学名药的发现。基于细胞的测定越来越多地用于评估重要参数，例如细胞活力、细胞毒性和衰老，特别是在高通量筛检环境中。此外，对干细胞检测的投资增加和研究倡议的加强正在支持更安全的治疗方法的出现。医学研究和药物发现对干细胞检测的需求不断增长，加上製药业的扩张，继续推动这个充满活力的市场向前发展。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 监管环境
• 专利分析
• 案例研究

按产品类型和复合年增长率分類的干细胞检测市场规模（2024-2031）

• 市场概况
• 装置
  • 流式细胞仪
  • 微电极阵列
  • 细胞成像系统
• 消耗品
  • 试剂和套件
  • 微孔盘
  • 检测试剂套件

干细胞检测市场规模：依检测类型及复合年增长率（2024-2031）

• 市场概况
• 细胞活力和毒性测定
  • MTT试验
  • 台盼蓝排除试验
• 细胞鑑定测试
  • 免疫细胞化学
  • 流式细胞技术
• 细胞增殖测试
  • Brdu 测定
  • 教育分析
• 细胞分化测试
  • 碱性磷酸酶测试
  • 萤光测定
• 其他的
  • 细胞凋亡检测
  • 移动测试

干细胞检测市场规模：依应用和复合年增长率（2024-2031）

• 市场概况
• 再生医学和治疗方法的发展
  • 神经病学
  • 肿瘤学
  • 心血管
• 药物发现与开发
  • 毒性试验
  • 功效测试
• 临床调查
  • 疾病模型
  • 干细胞表征

干细胞检测市场规模：依最终用户和复合年增长率（2024-2031）

• 市场概况
• 製药和生物技术公司
  • 药物开发
  • 品管
• 学术研究所
  • 基础调查
  • 转化研究
• 合约调查机构（Cros）
  • 临床前研究
  • 临床试验

干细胞检测市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Thermo Fisher Scientific Inc.（USA）
• Merck KGaA（Germany）
• Danaher Corporation（USA）
• Becton, Dickinson and Company（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Promega Corporation（USA）
• Bio-Techne Corporation（USA）
• FUJIFILM Holdings Corporation（Japan）
• Charles River Laboratories（USA）
• HemoGenix, Inc.（USA）
• Lonza Group（Switzerland）
• Takara Bio Inc.（Japan）
• Creative Bioarray（USA）
• AAT Bioquest, Inc.（USA）
• BPS Bioscience, Inc.（USA）
• Enzo Biochem, Inc.（USA）
• PromoCell GmbH（Germany）
• Biotium, Inc.（USA）
• Geno Technology, Inc.（USA）

结论和建议

Global Stem Cell Assay Market size was valued at USD 1.9 billion in 2022 and is poised to grow from USD 2.24 billion in 2023 to USD 8.24 billion by 2031, growing at a CAGR of 17.7% during the forecast period (2024-2031).

The stem cell assay market is experiencing significant growth driven by the consistent availability of hard-to-source cell types and the development of physiologically relevant models. Recent advancements in medical infrastructure and technology innovations have transformed treatment protocols and facilitated the discovery of novel therapies and generic drugs. Cell-based assays are increasingly employed to evaluate key parameters such as cell viability, cytotoxicity, and senescence, particularly within high-throughput screening environments. Furthermore, heightened investment and intensified research initiatives in stem cell assays have fostered the emergence of safer treatment options. The rising demand for stem cell-based assays in medical research and drug discovery, coupled with the expansion of the pharmaceutical sector, continues to propel this dynamic market forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Assay Market Segmental Analysis

Global Stem Cell Assay Market is segmented by product type, assay type, application, end-user and region. Based on product type, the market is segmented into instruments and consumables. Based on assay type, the market is segmented into cell viability & toxicity assays, cell identification assays, cell proliferation assays, cell differentiation assays and others. Based on application, the market is segmented into regenerative medicine & therapy development, drug discovery & development and clinical research. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes and contract research organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Stem Cell Assay Market

The global stem cell assay market is fundamentally influenced by a rising health consciousness among the population and ongoing population growth. While the COVID-19 pandemic posed significant challenges for various sectors, the stem cell assay market demonstrated resilience, with key players maintaining their product offerings despite the downturn. The continuous advancements in stem cell assays not only address the complexities of global demand but also enhance the quality of care provided to patients. As health awareness escalates, the demand for innovative stem cell assays is likely to grow, positioning the market for sustained development in the future.

Restraints in the Global Stem Cell Assay Market

The Global Stem Cell Assay market faces several restraints, one of the most significant being the high cost of raw materials. This economic challenge affects various industrial sectors, hindering their ability to maintain sustainable production operations. The elevated expenses associated with sourcing essential materials can lead to increased pricing for finished products, ultimately impacting market growth and accessibility. Companies in the stem cell research and therapeutic fields may struggle to balance the need for quality inputs with budget constraints, potentially limiting innovation and the advancement of stem cell technologies. Therefore, addressing this financial barrier is crucial for the market's overall development.

Market Trends of the Global Stem Cell Assay Market

The Global Stem Cell Assay market is witnessing a notable upward trend, driven by the rising emphasis on personalized medicine and regenerative therapies. This greater focus has catalyzed the demand for stem cell assays, essential for streamlining drug discovery and development processes. Furthermore, significant technological advancements and the integration of automation have markedly improved the efficiency and accuracy of these assays, resulting in superior research outcomes and cost-effectiveness. As pharmaceutical companies and research institutions increasingly prioritize these innovative approaches, the stem cell assay market is poised for substantial growth, reflecting broader shifts toward precision and tailored healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Stem Cell Assay Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Instruments
  • Flow Cytometers
  • Microelectrode Arrays
  • Cell Imaging Systems
• Consumables
  • Reagents & Kits
  • Microplates
  • Assay Kits

Global Stem Cell Assay Market Size by Assay Type & CAGR (2024-2031)

• Market Overview
• Cell Viability & Toxicity Assays
  • Mtt Assay
  • Trypan Blue Exclusion Assay
• Cell Identification Assays
  • Immunocytochemistry
  • Flow Cytometry
• Cell Proliferation Assays
  • Brdu Assay
  • Edu Assay
• Cell Differentiation Assays
  • Alkaline Phosphatase Assay
  • Immunofluorescence Assay
• Others
  • Apoptosis Assays
  • Migration Assays

Global Stem Cell Assay Market Size by Application & CAGR (2024-2031)

• Market Overview
• Regenerative Medicine & Therapy Development
  • Neurology
  • Oncology
  • Cardiovascular
• Drug Discovery & Development
  • Toxicology Testing
  • Efficacy Testing
• Clinical Research
  • Disease Modeling
  • Stem Cell Characterization

Global Stem Cell Assay Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Pharmaceutical & Biotechnology Companies
  • Drug Development
  • Quality Control
• Academic & Research Institutes
  • Basic Research
  • Translational Research
• Contract Research Organizations (Cros)
  • Preclinical Studies
  • Clinical Trials

Global Stem Cell Assay Market Size & CAGR (2024-2031)

• North America (Product Type, Assay Type, Application, End-User)
  • USA
  • Canada
• Europe (Product Type, Assay Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Assay Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Assay Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Assay Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HemoGenix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AAT Bioquest, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BPS Bioscience, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Biochem, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotium, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geno Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations